The company's stock was tracking for a record close and clinched a fresh intraday record.
Philip Morris International (PM) shares climbed to an all-time high Tuesday after the tobacco giant posted better-than-expected results and raised its outlook on soaring demand for its non-cigarette products.
Philip Morris International Inc. (NYSE:PM ) Q3 2024 Earnings Conference Call October 22, 2024 9:00 AM ET Company Participants James Bushnell – Vice President-Investor Relations and Financial Communications Emmanuel Babeau – Chief Financial Officer Conference Call Participants Bonnie Herzog – Goldman Sachs Gaurav Jain – Barclays Faham Baig – UBS Priya Ohri-Gupta – Barclays Gaurav Jain – Barclays Operator Good day and thank you for standing by. Welcome to the Philip Morris International Inc., 2024 Third Quarter Results Conference Call.
Jacek Olczak, Philip Morris CEO, joins 'Money Movers' to discuss the company's quarterly earnings results, what's driving the accelerated demand growth, and the company's margin picture.
Philip Morris' third-quarter 2024 results reflect robust momentum across all regions and product categories. Management raises guidance for 2024.
Although the revenue and EPS for Philip Morris (PM) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Quarterly reports from Dow component 3M Co (NYSE:MMM) and Philip Morris International Inc. (NYSE:PM) are in focus this morning.
Philip Morris (PM) came out with quarterly earnings of $1.91 per share, beating the Zacks Consensus Estimate of $1.83 per share. This compares to earnings of $1.67 per share a year ago.
Philip Morris International raised its annual profit forecast after beating third-quarter estimates on Tuesday, betting on higher prices and resilient demand for its heated tobacco products and ZYN nicotine pouches.
Philip Morris is expected to see healthy EPS growth in the upcoming results, even as revenue growth can soften. But it's hard to make a short-to-medium term Buy case for it considering its strong price gains so far this year. The stock's market multiples are uncomfortably high right now, and with market's prospects looking not-too-bad for Q4 2024, a swing towards defensives appears unlikely.
Philip Morris' Q3 results are likely to reflect gains from pricing and strength in smoke-free products, especially IQOS and ZYN.
Philip Morris is shifting from cigarettes to smokeless products like Zyn, driving growth and justifying a continued strong buy. The company's new Colorado factory and $800 million investment highlight the unprecedented demand for Zyn and show it's a once in a generation opportunity. Analysts project strong EPS and revenue growth, with Zyn's popularity potentially leading to even higher estimates.